The role of adipocytokines in adipocyte-related pathological processes

Drug News and Perspectives

Volumn 17, Issue 5, 2004, Pages 293-298

  Youn, Byung S ^a   Min, Sung Shik ^a   Park, Kyong Soo ^b   Lee, Hyeon W ^c   Yu, Rina ^c   Kwon, Byoung S ^c,d  

^a Korea University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c University of Ulsan   (South Korea)

^d LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE; FATTY ACID; GLUCOSE; INSULIN; INTERLEUKIN 6; PROTEIN ACRP30; PROTEIN ADIPOQ; PROTEIN APM1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; CYTOKINE PRODUCTION; DIABETES MELLITUS; ENERGY; FATTY ACID METABOLISM; GLUCOSE BLOOD LEVEL; HUMAN; MEDICAL RESEARCH; METABOLIC DISORDER; OBESITY; PATHOPHYSIOLOGY; PROCESS MODEL; REVIEW;

ADIPOCYTES; ADIPONECTIN; ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE; HORMONES, ECTOPIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OBESITY; RESISTIN;

EID: 4043130326     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2004.17.5.829032     Document Type: Review

References (46)

1. Maeda, K., Okubo, K., Shimomura, I. et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Most Abundant Gene Transcript 1). Biochem Biophys Res Commun 1996, 221: 286-9.
2. Nakano, Y., Tobe, T., Choi-Miura, N.H. et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996, 20: 803-12.
3. Scherer P.E., Williams, S., Fogliano, M. et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270: 26746-9.
4. Hu, E., Ling, P. and Spiegelman, B.M. Adipo Q is a novel adipose-specific gene deregulated in obesity. J Biol Chem 1996, 271: 10697-703.
5. Berg, A.H., Combs, T.P. and Scherer, P.E. Acrp30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002, 13: 84-9.
6. Scapiro, L. and Scherer, P.E. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 1998, 8: 335-8.
7. Taso, T.S., Murrey, H.E., Hug, C., Lee, D.H. and Lodish, H.F. Oligomerization state-dependent activation of NF-kappaB signaling pathway by Acrp30. J Biol Chem 2002, 277: 29359-62.
8. Waki, H., Yamauchi, T., Kamon, J. et al. Impaired multimerization of human adiponectin mutants associated with diabetes. J Biol Chem 2003, 278: 40352-63.
9. Frubies, J., Tsao, T.-S., Javorschi, S. et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001, 98: 2005-10.
10. Tomas, E., Tsao, T.-S., Saha, A.K. et al. Enhanced muscle fat oxidation and glucose transport by Acrp30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 2002, 99: 16309-13.
11. Wang, Y., Xu, A., Knight, C., Xu, L.Y. and Cooper, G.J.S. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. J Biol Chem 2002, 277: 19521-9.
12. Berg, A.H., Combs, T.P., Du, X., Brownlee, M. and Scherer, P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001, 7: 947-53.
13. Yamauchi, T., Kamon, J., Waki, H. et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7: 941-6.
14. Yamauchi, T., Kamon, J., Minokoshi, Y. et al. Adiponectin stimulates utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8: 1-8.
15. Arita, Y., Kihara, S., Ouchi, N. et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257: 79-83.
16. Kumada, M., Kihara, S., Sumitsuji, S. et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23: 85-9.
17. Adamczak, M., Wiecek, A., Funahshi, T., Chudek, J., Kokot, F. and Matsuzawa, Y. Decreased plasma adiponectin concentration in patient essential hypertension. Am J Hypertens 2003, 16: 72-5.
18. Okamoto, Y., Kihara, S., Ouchi, N. et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002, 106: 2767-70.
19. Ouchi, N., Kihara, S., Arita, Y. et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000, 102: 1296-301.
20. Yokota, T., Oritani, K., Takahashi, I. et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96: 1723-32.
21. Ouchi, N., Kihara, S. and Funahashi, T. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003, 107: 671-4.
22. Pajvani, U.B., Du, X., Combs, T.P. et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. J Biol Chem 2003, 278: 9073-85.
23. Lindsay R.S., Funahashi, T., Hanson, R.L. et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360: 57-8.
24. Spranger, J., Kroke, A., Mohlig M. et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003, 361: 226-8.
25. Kondo, H., Shimomura, I., Matsukawa, Y. et al. Association of adiponectin mutation with type 2 diabetes candidate gene for the insulin resistance syndrome. Diabetes 2003, 51: 2325-8.
26. Hara, K., Boutin, P., Mori, Y. et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in Japanese population. Diabetes 2002, 51: 536-40.
27. Vionnet, N., Hani, E.-H., Dupont, S. et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000, 67: 1470-80.
28. Maeda, N., Shimomura, I., Kishda, K. et al. Diet-induced insulin resistance in mice lacking adiponectin/Acrp30. Nat Med 2002, 8: 731-7.
29. Ma, K., Cabrero, A. and Saha, P.K. Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 2002, 277: 34658-61.
30. Kubota, N., Terauchi, Y., Yamamuchi, T. et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002, 277: 25863-6.
31. Yamauchi, T., Kamon, J., Waki, H. et al. Globular adiponectin protected ob/ob mice from diabetes and apoE-deficient mice from atherosclerosis. J Biol Chem 2003, 278: 2461-8.
32. Yamamuchi, T., Kamon, J., Ito, Y. et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423: 762-9.
33. Chen, H., Montagnan, M., Funahashi, T., Shimomura, I. and Quon, M.J. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003, 278: 45021-6.
34. Ouchi, N., Kobayashi, H. and Kihara, S. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004, 279: 1304-9.
35. Hattori, Y., Suzuki, M., Hattori, S. and Kasai, K. Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 2003, 46: 1543-9.
36. Yokota, T., Reddy Meka, C.S., Kouro, T. et al. Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol 2003, 171: 5091-9.
37. Yokota, T., Reddy Meka, C.S. and Medina, K.L. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 2002, 109: 1303-10.
38. Banerjee, R. and Lazar, M.A. Dimerization of resistin and resistin-like molecules is determined by a single cysteine. J Biol Chem 2001, 276: 25970-3.
39. Kim, K.-H., Lee, K., Moon, S.M. and Sul, H.S. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276: 11252-6.
40. Steppan, C.M., Bailey, S.T., Bhat, S. et al. The hormone resistin links obesity to diabetes. Nature 2001, 409: 307-12.
41. Moon, B., Kwan, J.J., Duddy, N., Sweeney, G. and Begum, N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J Physiol Endocrinol Metab 2003, 285: E106-15.
42. Juan, C.-C., Kan, L.-S., Huang, C.-C., Chen, S.-S., Ho, L.-T. and Au, L.-C. Production and characterization of bioactive recombinant resistin in Escherichia coli. J Biotechnol 2003, 103: 113-7.
43. Way, J.M., Gorgun, C.Z. and Tong, Q. Adipose tissue resistin expression is selectively suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma-agonists. J Biol Chem 2001, 276: 25651-3.
44. Silha, J.V., Kresk, M., Skrha, J.V., Sucharada, P., Nyomba, B.L.G. and Murphy, L.J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: Correlations with insulin resistance. Eur J Endocrinol 2003, 149: 331-5.
45. Youn, B.-S., Yu, K.-Y., Park, H.-J. et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004, 89: 150-6.
46. Rajala, M.W., Obici, S., Scherer, P.E. and Rossetti, L. Adipose-derived resistin and gut-derived resistin-like molecule-b selectively impair insulin action on glucose production. J Clin Invest 2003, 111: 225-30.